Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Storm Newton

Breakthrough for prostate cancer patients as NHS now offers life-extending drug

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, talazoparib, which has been approved for NHS use.

The once-daily pill, with its brand name Talzenna and produced by Pfizer, offers a crucial at-home treatment option after receiving a recommendation from the National Institute for Health and Care Excellence (Nice).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.